IDISPENSE Trademark

Trademark Overview

On Tuesday, October 9, 2018, a trademark application was filed for IDISPENSE with the United States Patent and Trademark Office. The USPTO has given the IDISPENSE trademark a serial number of 88148108. The federal status of this trademark filing is REGISTERED as of Tuesday, June 16, 2020. This trademark is owned by Karis Pharmaceuticals, LLC. The IDISPENSE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Dispensing of pharmaceuticals and biologic tissue
idispense

General Information

Serial Number88148108
Word MarkIDISPENSE
Filing DateTuesday, October 9, 2018
Status700 - REGISTERED
Status DateTuesday, June 16, 2020
Registration Number6080948
Registration DateTuesday, June 16, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 30, 2019

Trademark Statements

Pseudo MarkI DISPENSE
Goods and ServicesDispensing of pharmaceuticals and biologic tissue

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 18, 2018
Primary Code044
First Use Anywhere DateMonday, March 30, 2020
First Use In Commerce DateMonday, March 30, 2020

Trademark Owner History

Party NameKaris Pharmaceuticals, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressEl Dorado Hills, CA 95762
Party NameKaris Pharmaceuticals, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressEl Dorado Hills, CA 95762
Party NameKaris Pharmaceuticals, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEl Dorado Hills, CA 95762

Trademark Events

Event DateEvent Description
Thursday, January 24, 2019NON-FINAL ACTION WRITTEN
Friday, October 12, 2018NEW APPLICATION ENTERED
Thursday, October 18, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 18, 2019ASSIGNED TO EXAMINER
Thursday, January 24, 2019NON-FINAL ACTION E-MAILED
Thursday, January 24, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 28, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 28, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 28, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, June 8, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 21, 2019ASSIGNED TO LIE
Tuesday, July 30, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, July 10, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 30, 2019PUBLISHED FOR OPPOSITION
Tuesday, September 24, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 20, 2020SOU TEAS EXTENSION RECEIVED
Friday, March 20, 2020SOU EXTENSION 1 FILED
Friday, March 20, 2020SOU EXTENSION 1 GRANTED
Tuesday, March 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 30, 2020TEAS STATEMENT OF USE RECEIVED
Monday, March 30, 2020USE AMENDMENT FILED
Wednesday, April 15, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 15, 2020STATEMENT OF USE PROCESSING COMPLETE
Friday, May 15, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, May 14, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, June 16, 2020REGISTERED-PRINCIPAL REGISTER
Monday, June 16, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

idispense tissue biologic pharmaceuticals dispensing